Oventus Medical Ltd

ASX:OVN ISIN:AU000000OVN3

Oventus Medical Ltd (ASX:OVN) is a Brisbane based medical device company that is commercialising a suite of oral appliances for the treatment of sleep apnoea and snoring. Unlike other oral appliances, the Oventus devices have a unique and patented airway within the device that delivers air to the back of the mouth bypassing multiple obstructions from the nose, soft palate and tongue. They are particularly designed for the many people that have nasal obstructions and consequently tend to mainly breathe through their mouth. While it may seem counterintuitive, the device actually prevents oral breathing. The O2Vent is designed to allow nasal breathing when the nose is unobstructed, but when obstruction is present, breathing is supplemented via the airways in the appliance.

A clinical study completed earlier this year showed the company's first generation product the O2Vent Mono(TM) is successful in treating OSA and that snoring was either eliminated or significantly reduced to 100 per cent of patients. The positive results included those people who had nasal obstructions and mainly breathed through their mouths, including when they were asleep. It also improves oxygen levels for patients.

According to a report published by the Sleep Health Foundation Australia, an estimated 1.5 million Australians suffer with sleep disorders and more than half of these suffer with obstructive sleep apnoea.

Continuous positive airway pressure (CPAP) is the most definitive medical therapy for obstructive sleep apnoea, OSA, however many patients have difficulty tolerating CPAP. Oral appliances have emerged as an alternative to CPAP for obstructive sleep apnoea treatment.

       

News

Oventus Medical Ltd (ASX:OVN) Investor Presentation

🕔9/27/2017 8:23:33 AM 1083

Oventus Medical Ltd (ASX:OVN) provide the latest Investor Presentation.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Audited Financial Statements and Appendix 4E

🕔8/31/2017 1:27:22 PM 1417

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to release its Appendix 4E with its full year audited general purpose financial report for the period ending 30 June 2017.

Read Full Article

FINANCE VIDEO: Oventus Medical Ltd (ASX:OVN) Financial News Network Interview

🕔8/24/2017 10:00:45 AM 2552

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) is pleased to share Dr Chris Hart's interview on Financial News Network.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Appendix 4C - Quarterly Cash Flow Report

🕔7/31/2017 9:45:46 AM 2019

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has today released its Appendix 4C - Quarterly cash flow report for the period ended 30 June 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Extension of Share Purchase Plan

🕔7/14/2017 11:26:52 AM 1342

Oventus Medical Limited (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. Oventus wishes to advise that the closing date for the SPP will be extended from Wednesday 19 July 2017 to Monday 31 July 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Receives FDA Clearance for the O2Vent W

🕔7/12/2017 9:29:37 AM 1429

Australian medical device company, Oventus Medical Ltd. (ASX:OVN) has received FDA 510k clearance for its O2Vent W device, an oral appliance intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnoea.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Share Purchase Plan Documents Issued to Shareholders

🕔6/27/2017 10:02:34 AM 1660

Oventus Medical Ltd (ASX:OVN) announced a share purchase plan to the market on 22 June 2017. The record date to be registered as a shareholder for participation in the SPP is Wednesday, 21 June 2017.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Successful Capital Raising

🕔6/22/2017 10:07:35 AM 1757

Oventus Medical Limited (ASX:OVN) announces that it has completed a first tranche placement of approximately 18 million shares to institutional and sophisticated investors at an issue price of $0.36 per share to raise approximately $6.5 million.

Read Full Article

Oventus Medical Ltd (ASX:OVN) World-wide Distribution Agreement with Modern Dental Group (HKG:3600)

🕔6/20/2017 8:32:10 AM 1839

Oventus Medical Ltd (ASX:OVN) is pleased to announce it has entered into a world-wide distribution agreement with Hong Kong based Modern Dental Group (HKG:3600). This is in addition to the recent announcement of the co-manufacturing agreement between Oventus and Modern Dental.

Read Full Article

Oventus Medical Ltd (ASX:OVN) Positive Clinical Data Presented at US Dental Sleep Meeting

🕔6/7/2017 9:24:56 AM 1655

Oventus Medical Ltd (ASX:OVN) is pleased to announce that low pressure CPAP without a mask is one step closer. Results from the initial pilot study generated significant interest when presented at the American Academy of Dental Sleep Medicine in Boston on June 2nd 2017. The conference is the premier world forum for the latest developments in dental sleep medicine.

Read Full Article
###

7,236 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 116) (Last 30 Days: 548) (Since Published: 7236) 

Markets ASX:OVN

Company Data

    Headquarters
  • 1 Swann Road
    Indooroopilly
    PO Box 190, Indooroopilly
    4068 QLD Australia
  • Telephone
  • 1300 533 159 
  • Principal Sector
  • Chemical Equipment & Manufacturing 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.oventus.com.au

Company Reports

Presentations

Quarterly Report

Social Media